Results 21 to 30 of about 379,995 (308)

Advocacy coalition formation and key actors within the policy

open access: yesRevista de Administración Pública, 2020
The article discusses advocacy coalition formation and the roles of key actors in science, technology and innovation (ST&I) policies for social inclusion in a subnational context.
D. Rodrigues   +2 more
semanticscholar   +1 more source

Parent‐to‐Child Information Disclosure in Pediatric Oncology

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Despite professional consensus regarding the importance of open communication with pediatric cancer patients about their disease, actual practice patterns of disclosure are understudied. Extant literature suggests a significant proportion of children are not told about their diagnosis/prognosis, which is purported to negatively ...
Rachel A. Kentor   +12 more
wiley   +1 more source

Paying More for the American Dream - The Subprime Shakeout and Its Impact on Lower-Income and Minority Communities [PDF]

open access: yes, 2008
A joint report by: California Reinvestment Coalition, Community Reinvestment Association of North Carolina, Empire Justice Center, Massachusetts Affordable Housing Alliance, Neighborhood Economic Development Advocacy Project, Ohio Fair Lending Coalition,
Adam Rust   +6 more
core  

Advocacy, the Media and You: Change in a Time of Uncertainty [PDF]

open access: yes, 2010
Summarizes panel discussions and key lessons on building advocacy and media skills from an October 2009 convening of the Equal Voice Coalition to support a family-led advocacy movement.

core  

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background B‐acute lymphoblastic leukemia (B‐ALL) is the most common pediatric cancer, and while most children in high‐resource settings are cured, therapy carries risks for long‐term toxicities. Understanding parents’ concerns about these late effects is essential to guide anticipatory support and inform evolving therapeutic approaches ...
Kellee N. Parker   +7 more
wiley   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Supporting Minnesota's Youngest Citizens: Lessons Learned 2003-2006 [PDF]

open access: yes, 2006
Presents lessons learned from the efforts of six Minnesota foundations and their grassroots coalition partners to establish early education outreach, business relationship building, parenting education, quality child care, and advocacy ...

core  

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

open access: yesMolecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié   +13 more
wiley   +1 more source

Examining the advocacy coalition framework for insight into shale gas development in US and UK political systems [PDF]

open access: yes, 2014
Master's Project (M.S.) University of Alaska Fairbanks, 2014The project considers the Advocacy Coalition Framework from the discipline of policymaking which is used to examine contentious and politically complex policy issues, particularly in energy and ...
Wolfley, Kathryn
core  

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy